نتائج البحث

المساهمون: Maruzzo, M., Basso, U., Borsatti, E., Evangelista, L., Alongi, F., Caffo, O., Maines, F., Galuppo, S., De Vivo, R., Zustovich, F., Palleschi, D., Zivi, A., Sava, T., Soraru, M., Iacovelli, R., Nicodemo, M., Baier, S., Fratino, L., Zagonel, V.

مصطلحات موضوعية: Bone metastase, Prostate cancer, Radiometabolic therapy, Radium223, Real-world setting, Adult, Aged, 80 and over, Follow-Up Studie, Human, Italy, Lymphocyte, Male, Middle Aged, Neutrophil, Prostatic Neoplasms, Castration-Resistant, Radium, Retrospective Studie, Survival Rate, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30448106; info:eu-repo/semantics/altIdentifier/wos/WOS:000456341000026; volume:17; issue:1; firstpage:e187; lastpage:e194; journal:CLINICAL GENITOURINARY CANCER; http://hdl.handle.net/11577/3341704Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85056572157; http://www.journals.elsevier.com/clinical-genitourinary-cancerTest/

الإتاحة: https://doi.org/10.1016/j.clgc.2018.10.013Test
http://hdl.handle.net/11577/3341704Test
http://www.journals.elsevier.com/clinical-genitourinary-cancerTest/

View record in BASE

4

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

المصدر: European Urology Oncology, 3, 2, pp. 176-182
European Urology Oncology
European Urology Oncology, 3, 176-182
Università degli studi di Foggia-IRIS

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Time Factors, Urology, 030232 urology & nephrology, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Nitriles, Phenylthiohydantoin, Enzalutamide, Humans, Medicine, Overall survival, Radiology, Nuclear Medicine and imaging, Retrospective Studies, business.industry, Proportional hazards model, Abiraterone acetate, Cancer, Généralités, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Prostate-specific antigen, Confidence interval, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Benzamides, Androstenes, Surgery, business, Cohort study, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: 1 full-text file(s): application/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5dd1057d25e399665b90b59cfd6f7abTest
https://hdl.handle.net/2066/218771Test

5

دورية أكاديمية

Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region

المؤلفون: Maruzzo, Marco, Basso, Umberto, Borsatti, Eugenio, Evangelista, Laura, Alongi, Filippo, Caffo, Orazio, Maines, Francesca, Galuppo, Sara, De Vivo, Rocco, Zustovich, Fable, Palleschi, Dario, Zivi, Andrea, Sava, Teodoro, Sorarù, Mariella, Iacovelli, Roberto, Nicodemo, Maurizio, Baier, Susanne, Fratino, Lucia, Zagonel, Vittorina

المساهمون: Maruzzo, Marco, Basso, Umberto, Borsatti, Eugenio, Evangelista, Laura, Alongi, Filippo, Caffo, Orazio, Maines, Francesca, Galuppo, Sara, De Vivo, Rocco, Zustovich, Fable, Palleschi, Dario, Zivi, Andrea, Sava, Teodoro, Sorarù, Mariella, Iacovelli, Roberto, Nicodemo, Maurizio, Baier, Susanne, Fratino, Lucia, Zagonel, Vittorina

مصطلحات موضوعية: Bone metastase, Prostate cancer, Radiometabolic therapy, Radium223, Real-world setting

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30448106; info:eu-repo/semantics/altIdentifier/wos/WOS:000456341000026; journal:CLINICAL GENITOURINARY CANCER; http://hdl.handle.net/11379/511253Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85056572157

الإتاحة: https://doi.org/10.1016/j.clgc.2018.10.013Test
http://hdl.handle.net/11379/511253Test

View record in BASE